1. Resistin-like molecules: a marker, mediator and therapeutic target for multiple diseases
- Author
-
Yaning Shi, Neng Zhu, Yun Qiu, Junlan Tan, Feiying Wang, Li Qin, and Aiguo Dai
- Subjects
Resistin-like molecules ,Inflammation ,Proliferation ,Parasite ,Lung disease ,Medicine ,Cytology ,QH573-671 - Abstract
Abstract Resistin-like molecules (RELMs) are highly cysteine-rich proteins, including RELMα, RELMβ, Resistin, and RELMγ. However, RELMs exhibit significant differences in structure, distribution, and function. The expression of RELMs is regulated by various signaling molecules, such as IL-4, IL-13, and their receptors. In addition, RELMs can mediate numerous signaling pathways, including HMGB1/RAGE, IL-4/IL-4Rα, PI3K/Akt/mTOR signaling pathways, and so on. RELMs proteins are involved in wide range of physiological and pathological processes, including inflammatory response, cell proliferation, glucose metabolism, barrier defense, etc., and participate in the progression of numerous diseases such as lung diseases, intestinal diseases, cardiovascular diseases, and cancers. Meanwhile, RELMs can serve as biomarkers, risk predictors, and therapeutic targets for these diseases. An in-depth understanding of the role of RELMs may provide novel targets or strategies for the treatment and prevention of related diseases. Video abstract
- Published
- 2023
- Full Text
- View/download PDF